TLRY Nasdaq Medicinal Chemicals & Botanical Products Financials FY2017βFY2026
Tilray Brands, Inc. had $915M of revenue in fiscal 2026, up 11.5% on the year before. Over five years, revenue changed +84.2% a year on average.
Last close Β· Oct 23, 2026
$2.81
4.1%Hi! I read Tilray Brands, Inc.βs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
+11.5%
Yes. Sales grew 11.5% last year.
Does it make a profit?
β13.3%
No. It lost money last year.
How healthy are the accounts?
2 / 9
Weak. It passes 2 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Tilray Brands, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
January 7, 2027
Thursday Β· in 73 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
See who else reports that week β| Date | Results for | Time | Source |
|---|---|---|---|
| Oct 8, 2026 | Q1 '27 | Before the market opens | 8-K β |
| Jul 28, 2026 | Q4 '26 | After the market closes | 8-K β |
| Apr 1, 2026 | Q3 '26 | Before the market opens | 8-K β |
| Jan 8, 2026 | Q2 '26 | After the market closes | 8-K β |
| Oct 9, 2025 | Q1 '26 | Before the market opens | 8-K β |
| Jul 28, 2025 | Q4 '25 | After the market closes | 8-K β |
| Apr 8, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Jan 10, 2025 | Q2 '25 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Tilray Brands, Inc. had $915M of revenue in fiscal 2026, up 11.5% on the year before. Over five years, revenue changed +84.2% a year on average. Its operating margin was β6.9%, up 271.1Β pts: of every 100 in sales, about β7 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Tilray Brands, Inc. lost $121M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Tilray Brands, Inc. owes $22.7M more than it holds in cash.
Cash, debt and the ratios that show how comfortably Tilray Brands, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $416M | $449M | $261M | $256M | $231M |
| Debt incl. finance leases | $204M | $23.4M | $63.1M | $53.0M | $254M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| Interest coverage | β15.4x | β29.4x | β3.5x | β55.2x | β2.1x |
| Current ratio | 2.9x | 1.8x | 2.3x | 2.5x | 2.2x |
| Quick ratio | 2.0x | 1.3x | 1.4x | 1.5x | 1.4x |
| Total assets | $5.4B | $4.3B | $4.2B | $2.1B | $2.3B |
| Total liabilities | $1.0B | $977M | $778M | $585M | $733M |
| Shareholders' equity | $4.4B | $3.3B | $3.4B | $1.5B | $1.6B |
| Net debt (β = net cash) | β$212M | β$425M | β$197M | β$203M | $22.7M |
KIRA Β· Its return on capital was β3.3%: every 100 invested in the business earned about β3 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Tilray Brands, Inc. passes 2 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | β / 3 | 3 / 9 | 5 / 9 | 7 / 9 | 5 / 9 | 2 / 9 |
| Accruals ratio | β | β3.3% | β0.4% | β5.2% | β29.9% | β5.0% | β66.5% | β2.4% |
| Altman Z'' | β | β8.06 | 3.20 | 3.88 | 0.12 | 2.90 | β11.01 | β3.61 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $12.6M | $20.5M | $43.1M | $628M | $627M | $789M | $821M | $915M |
| Gross profit | $2.7M | $11.4M | $14.3M | $117M | $147M | $223M | $241M | $260M |
| Research and development | $1.1M | $3.2M | $5.9M | $1.5M | $0.7M | $0.6M | $0.3M | $0.4M |
| Operating income | β$7.0M | β$7.5M | β$57.8M | β$610M | β$1.4B | β$175M | β$2.3B | β$63.0M |
| Interest expense | $0.8M | $0.7M | $5.7M | $39.7M | $46.6M | $49.3M | $41.3M | $29.9M |
| Pretax income | β$7.9M | β$7.8M | β$72.2M | β$441M | β$1.5B | β$249M | β$2.3B | β$88.1M |
| Income tax | β | β | β$4.5M | β$6.5M | β$7.2M | β$26.6M | β$121M | $17.1M |
| Net income | β$7.9M | β$7.8M | β$67.7M | β$477M | β$1.5B | β$245M | β$2.2B | β$121M |
| Diluted EPS | β$0.11 | β$0.10 | β$0.82 | β$0.99 | β$2.35 | β$3.30 | β$24.56 | β$1.09 |
| Diluted shares | 0.08B | 0.08B | 0.08B | 0.48B | 0.62B | 0.07B | 0.09B | 0.11B |
| Cash flow | ||||||||
| Cash from operations | β$3.3M | β$6.0M | β$46.2M | β$177M | $7.9M | β$30.9M | β$94.6M | β$69.1M |
| Capital expenditure | $0.5M | $10.9M | $50.2M | $34.1M | $20.8M | $29.2M | $32.9M | β |
| Free cash flow | β$3.8M | β$16.9M | β$96.4M | β$211M | β$12.9M | β$60.2M | β$128M | β |
| Depreciation and amortization | $2.0M | $1.9M | $3.6M | $155M | β | β | β | β |
| Stock-based compensation | $0.1M | $0.1M | $21.0M | $36.0M | $39.6M | $31.8M | $24.3M | $45.9M |
| Acquisitions | β | β | β | β$0.3M | $26.7M | $60.6M | $18.1M | $53.7M |
| Balance sheet | ||||||||
| Cash and short-term investments | $7.5M | $2.3M | $488M | $416M | $449M | $261M | $256M | $231M |
| Total debt | β | $9.4M | $213M | $204M | $23.4M | $18.0M | $7.2M | $129M |
| Finance lease liabilities | β | β | β | β | β | $45.0M | $45.9M | $125M |
| Current assets | β | $12.4M | $884M | $804M | $773M | $678M | $689M | $792M |
| Current liabilities | β | $50.2M | $401M | $280M | $433M | $299M | $280M | $358M |
| Inventory | β | $7.4M | $256M | $246M | $201M | $252M | $271M | $301M |
| Property and equipment, net | β | $40.0M | $651M | $587M | $430M | $558M | $568M | $680M |
| Goodwill | β | β | $2.8B | $2.6B | $2.0B | $2.0B | $752M | $752M |
| Intangible assets | β | $0.9M | $1.6B | $1.3B | $974M | $915M | $21.4M | $42.8M |
| Total assets | β | $53.9M | $6.0B | $5.4B | $4.3B | $4.2B | $2.1B | $2.3B |
| Total liabilities | β | $58.8M | $1.6B | $1.0B | $977M | $778M | $585M | $733M |
| Preferred stock | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.5M | β$4.9M | $4.5B | $4.4B | $3.3B | $3.4B | $1.5B | $1.6B |
| Margins | ||||||||
| Gross margin | 21.1% | 55.4% | 33.1% | 18.6% | 23.4% | 28.3% | 29.3% | 28.4% |
| Operating margin | β55.7% | β36.5% | β134.1% | β97.1% | β218.4% | β22.1% | β277.9% | β6.9% |
| EBITDA margin | β40.3% | β27.5% | β125.8% | β72.5% | β | β | β | β |
| Net margin | β62.3% | β38.0% | β157.0% | β75.9% | β231.6% | β31.1% | β266.3% | β13.3% |
| FCF margin | β30.1% | β82.3% | β223.6% | β33.6% | β2.1% | β7.6% | β15.5% | β |
| Returns | ||||||||
| Return on capital | β | β262.4% | β1.1% | β11.5% | β37.4% | β4.3% | β142.9% | β3.3% |
| Return on capital employed | β | β201.2% | β1.0% | β11.8% | β35.4% | β4.5% | β127.2% | β3.2% |
| Return on equity | β311.8% | β | β1.5% | β10.8% | β37.7% | β7.2% | β88.3% | β7.8% |
| Return on assets | β | β14.5% | β1.1% | β8.3% | β29.8% | β5.7% | β69.5% | β5.5% |
| Return on tangible equity | β311.8% | β | β332.7% | β99.4% | β436.1% | β47.2% | β296.4% | β14.8% |
| Growth | ||||||||
| Revenue growth | β | 62.4% | β | 1,356.9% | β0.2% | 25.8% | 4.1% | 11.5% |
| Share count change | β | 0.0% | β | 479.7% | 28.4% | β88.0% | 19.9% | 25.6% |
| Financial health | ||||||||
| Debt / equity | β | β | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| Interest coverage | β9.1x | β10.8x | β10.2x | β15.4x | β29.4x | β3.5x | β55.2x | β2.1x |
| Current ratio | β | 0.2x | 2.2x | 2.9x | 1.8x | 2.3x | 2.5x | 2.2x |
| Quick ratio | β | 0.1x | 1.6x | 2.0x | 1.3x | 1.4x | 1.5x | 1.4x |
| Capital allocation | ||||||||
| Capex / revenue | 3.9% | 53.1% | 116.4% | 5.4% | 3.3% | 3.7% | 4.0% | β |
| Stock comp / revenue | 0.7% | 0.7% | 48.7% | 5.7% | 6.3% | 4.0% | 3.0% | 5.0% |
| Quality scores | ||||||||
| Piotroski F-score | β | β | β | 3.0 | 5.0 | 7.0 | 5.0 | 2.0 |
| Altman Z'' | β | β8.1 | 3.2 | 3.9 | 0.1 | 2.9 | β11.0 | β3.6 |
| Accruals ratio | β | β3.3% | β0.4% | β5.2% | β29.9% | β5.0% | β66.5% | β2.4% |
Source: SEC EDGAR XBRL filings (CIK 0001731348). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
